Debt-addicted cos turn towards selling equity as interest costs skyrocket
Late last year, the chief financial officer at Myriad Genetics Inc. took a different tack, one the DNA-testing company hadn't seriously considered in over 16 years - selling shares
from Latest News https://ift.tt/UW7vOzQ
via WebMD https://bsmedia.business-standard.com/_media/bs/img/article/2023-04/10/thumb/1681146330-9217.jpg
ABOUT THE AUTHOR
Hello We are OddThemes, Our name came from the fact that we are UNIQUE. We specialize in designing premium looking fully customizable highly responsive blogger templates. We at OddThemes do carry a philosophy that: Nothing Is Impossible
